BridgeBio Pharma Stock Surges as Pfizer Patent Challenges Reshape the Heart Disease Market
The biotechnology sector witnessed a significant shift in market sentiment this week as BridgeBio Pharma experienced a notable breakout in share price.
by 
Josh Weiner
Josh Weiner